Diagnostic electrocardiograph (ECG) companies play a crucial role in the healthcare industry, providing cutting-edge technology to monitor and analyze the electrical activity of the heart. These companies contribute significantly to the early detection and diagnosis of various cardiac conditions, enabling healthcare professionals to provide timely and effective treatment.
Philips strengthens its cardiac care portfolio: In 2021, Royal Philips acquired BioTelemetry, Inc. and Capsule Technologies, strengthening its position in cardiac diagnostics and monitoring services. This move reflects the growing emphasis on remote patient monitoring and connected care solutions.
GE Healthcare collaborates on AI-powered ECG: In April 2022, GE Healthcare partnered with Deep Cardio to develop AI-based ECG diagnostic technology and data analysis programs. This highlights the increasing role of artificial intelligence in improving ECG interpretation and diagnostic accuracy.
Nihon Kohden: The Japanese company recently launched a new 12-lead ECG system with advanced features like AI-powered interpretation and remote monitoring capabilities.
BPL Medical Technologies: The Indian company partnered with a research institute to develop a low-cost, portable ECG device for rural healthcare settings.
Edan Instruments: The Chinese company received FDA approval for its new Holter monitor, expanding its product portfolio in the US market.
Diagnostic Electrocardiograph Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)